We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPOK:NASDAQSpok Holdings, Inc. Analysis

Data as of 2026-09-01 - not real-time

$10.51

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At $10.51, Spok Holdings, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 1.4%. With RSI at 44.3 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $10.28 and resistance at $11.60.
On valuation the read is undervalued — earnings multiple of 18.4 versus a 30.6 sector average, below the peer group. The 11.90% dividend yield looks stretched against payout coverage.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 27.3%, a beta of 0.24 and a maximum drawdown of 43.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

Revenue declined but adjusted EBITDA surged 22% on software momentum and cost cuts.Spok smashed earnings with a 33% EPS beat as software bookings nearly doubled from Q1 and cost discipline delivered a...Microsoft and our third-party vendors use cookies to store and access information such as unique IDs and personal...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 11.78
  • MACD momentum is negative
  • Maximum drawdown of 43.5%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 18.4 versus sector average of 30.6
  • Dividend yield of 11.90% looks stretched against payout coverage
  • Trading below the 200-day average of 11.78

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 18.4 versus sector average of 30.6
  • Dividend yield of 11.90% looks stretched against payout coverage
  • Revenue contracting at -1.9%

Key Metrics & Analysis

Financial Health

Revenue Growth-1.90%
Profit Margin9.00%
P/E Ratio18.4
ROE8.42%
ROA5.69%
Debt/Equity4.11
P/B Ratio1.6
Op. Cash Flow$28.6M
Free Cash Flow$20.8M
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI44.3
Support$10.28
Resistance$11.60
MA 20$10.83
MA 50$10.71
MA 200$11.78
MACDBearish
VolumeDecreasing
Fear & Greed Index92.07

Valuation

Fair Value$13.18
GradeUndervalued
TypeValue
Dividend Yield11.90%

Risk Assessment

Beta0.24
Volatility27.31%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.